george floyd. floyd s sister will join me in a few moments. and fallout from the interview with prince harry and meghan, alleging racism in the royal family. there s a conversation with you with harry. about how dark your baby is going to be? potentially, and what that would mean or look like. much more on that interview straight ahead this hour. but i want to get right to something we ve all been waiting for. the cdc releasing official guidance for americans who are fully vaccinated against the coronavirus. what can they do? where can they go? can you hug your family, or be inside without masks? dr. jonathan reiner joins me now. thanks for joining. this is good news. we can see some small gatherings, grandparent hugs. but dr. leana wen argues, it s too cautious. you should be cautious, right? she says the cdc should be saying if you re willing to get vaccinated, you should be able to travel freely. do you agree? i agree. this administration said that science wo
tonight the cdc releasing new coronavirus guidelines and it s good news for people who are fully vaccinated. they can visit other vaccinated people indoors without masks or social distancing. jury selection set to begin tomorrow in the trial of the former minneapolis police officer accused of killing george floyd. floyd s sister will join me in a few moments. and fallout from the harry and meghan explosive interview with oprah winfrey, alleging racism in the royal family and that someone expressed concern about the color of their son s skin. there s a conversation with you with harry. about how dark your baby is going to somebody. potentially and what that would mean or look like. much more on harry and meghan s interview straight ahead this hour. but i want to get right to something we have all been waiting for and that s the cdc releasing official guidance for americans who are fully vaccinated against coronavirus. what can they do? where can they go? c
Experts provide practical guidelines and key takeaways for health care professionals and policymakers on the implementation of bispecific antibodies in DLBCL (diffuse large B cell lymphoma), emphasizing safety, efficacy, and operational strategies.
A panel of experts examines unmet needs in the adoption of bispecific antibody therapy, emphasizing the importance of access and education for diverse stakeholders in oncology care to improve patient outcomes.
Robert Mancini, PharmD, reviews pharmacists’ pivotal role in operationalizing use of bispecifics in diffuse large B-cell lymphoma (DLBCL), overcoming challenges, and supporting direct patient care teams.